• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?

作者信息

Niscola Pasquale, Caravita Tommaso, Tatangelo Paola, Siniscalchi Agostina, de Fabritiis Paolo, Palumbo Roberto

机构信息

Hematology Unit, Department of Medical Specialties S. Eugenio Hospital (ASL Roma 2), Rome, Italy.

Nephrology Unit, Department of Medical Specialties S. Eugenio Hospital (ASL Roma 2), Rome, Italy.

出版信息

Blood Res. 2017 Sep;52(3):218-219. doi: 10.5045/br.2017.52.3.218. Epub 2017 Sep 25.

DOI:10.5045/br.2017.52.3.218
PMID:29043238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5641515/
Abstract
摘要

相似文献

1
Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?血液科医生和肾内科医生携手合作：推进针对血液系统恶性肿瘤的新型综合护理模式？
Blood Res. 2017 Sep;52(3):218-219. doi: 10.5045/br.2017.52.3.218. Epub 2017 Sep 25.
2
Barriers to end-of-life discussions among hematologists: A qualitative study.阻碍血液学家进行临终讨论的因素：一项定性研究。
Palliat Med. 2018 May;32(5):1021-1029. doi: 10.1177/0269216318759862.
3
The need for training in palliative care for physicians in other specialties: Brazilian nephrologists empowerment (or appropriation) on renal supportive care.其他专科医生对姑息治疗培训的需求：巴西肾脏病学家在肾脏支持治疗方面的能力提升（或自主掌握）
Ann Palliat Med. 2018 Oct;7(Suppl 3):S176-S186. doi: 10.21037/apm.2018.07.07. Epub 2018 Aug 3.
4
Regional social system for specialized medical care in hematologic malignancies: a pilot study.血液系统恶性肿瘤专科医疗的区域社会系统：一项试点研究。
Rural Remote Health. 2009 Jul-Sep;9(3):1106. Epub 2009 Jul 28.
5
Nephrologists and Integrated Kidney Disease Care: Roles and Skills Essential for Nephrologists for Future Success.肾脏病学家和肾脏疾病综合照护：未来成功所需的肾脏病学家的角色和技能。
Am J Kidney Dis. 2017 Jul;70(1):132-138. doi: 10.1053/j.ajkd.2017.02.372. Epub 2017 Apr 14.
6
Role of outpatient physicians in reporting of hematopoietic malignancies for statewide surveillance.门诊医生在全州范围内监测造血系统恶性肿瘤报告中的作用。
J Registry Manag. 2014 Fall;41(3):139-45.
7
Recovery opportunities, work-home conflict, and emotional exhaustion among hematologists and oncologists in private practice.私营医疗机构血液科医师和肿瘤医师的恢复机会、工作家庭冲突和情绪耗竭。
Psychol Health Med. 2017 Apr;22(4):462-473. doi: 10.1080/13548506.2016.1237666. Epub 2016 Sep 22.
8
Barriers to the Collaboration Between Hematologists and Palliative Care Teams on Relapse or Refractory Leukemia and Malignant Lymphoma Patients' Care: A Qualitative Study.血液科医生与姑息治疗团队在复发或难治性白血病及恶性淋巴瘤患者护理方面的合作障碍：一项定性研究
Am J Hosp Palliat Care. 2016 Dec;33(10):977-984. doi: 10.1177/1049909115611081. Epub 2015 Oct 22.
9
Nephrologists' management of patient medications in kidney transplantation: results of an online survey.肾脏移植中肾病学家对患者药物的管理：一项在线调查结果
J Eval Clin Pract. 2015 Oct;21(5):879-85. doi: 10.1111/jep.12394. Epub 2015 Jun 17.
10
Achieving dialysis safety: The critical role of higher-functioning teams.实现透析安全：高效团队的关键作用。
Semin Dial. 2019 May;32(3):266-273. doi: 10.1111/sdi.12778. Epub 2019 Mar 8.

引用本文的文献

1
Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature.一例患者同时患有前列腺癌、慢性髓性白血病和多发性骨髓瘤：病例报告及文献复习。
J Med Case Rep. 2023 Feb 5;17(1):35. doi: 10.1186/s13256-023-03753-z.

本文引用的文献

1
Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma.基线肾功能作为新诊断弥漫性大B细胞淋巴瘤患者的预后指标。
Blood Res. 2016 Jun;51(2):113-21. doi: 10.5045/br.2016.51.2.113. Epub 2016 Jun 23.
2
How I treat acute myeloid leukemia presenting with preexisting comorbidities.我如何治疗伴有基础合并症的急性髓系白血病。
Blood. 2016 Jul 28;128(4):488-96. doi: 10.1182/blood-2016-01-635060. Epub 2016 May 27.
3
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?肾功能损害患者参加 I 期临床试验的资格：是时候重新考虑了吗？
Eur J Cancer. 2014 Nov;50(17):2893-6. doi: 10.1016/j.ejca.2014.09.001. Epub 2014 Sep 17.
4
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?慢性肾脏病流行病学协作组胱抑素 C（CKD-EPI-CysC）方程对有症状多发性骨髓瘤初诊患者的总生存具有独立的预后价值；是否到了从 MDRD 方程转变为 CKD-EPI-CysC 方程的时候？
Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17.
5
Onconephrology: the latest frontier in the war against kidney disease.肿瘤肾脏病学：对抗肾脏病之战的最新前沿。
J Am Soc Nephrol. 2013 Jan;24(1):26-30. doi: 10.1681/ASN.2012070690. Epub 2012 Nov 8.
6
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature.异基因干细胞移植中膜性肾小球病的管理：最新文献
Cardiovasc Hematol Agents Med Chem. 2013 Mar;11(1):67-76. doi: 10.2174/1871525711311010011.
7
Management of hematological malignancies in patients affected by renal failure.肾衰竭患者血液恶性肿瘤的治疗。
Expert Rev Anticancer Ther. 2011 Mar;11(3):415-32. doi: 10.1586/era.11.2.
8
The use of major analgesics in patients with renal dysfunction.肾功能障碍患者中主要镇痛药的使用。
Curr Drug Targets. 2010 Jun;11(6):752-8. doi: 10.2174/138945010791170879.
9
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.癌症患者肾功能不全的患病率及其对抗癌药物管理的影响：肾功能不全与抗癌药物（IRMA）研究
Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904.